baber/WOPTO huggingface dataset:
Patent CA-2392472-A1 (CA)
Inventor: NAKANISHI ATSUSHI
IPC: A61P11/06
Filed: 2000-11-22
Abstract: L'invention concerne de l'ADN antisens relatif à un gène associé à une maladie; des médicaments renfermant cet ADN; un anticorps vis-à-vis d'un produit génique associé à une maladie; des produits diagnostiques renfermant l'anticorps en question; un procédé de criblage de composé inhibant l'activité du produit génique susmentionné; des composés résultant de l'utilisation du procédé de criblage, etc. Un composé inhibant l'activité d'une protéine ayant un acide aminé identique ou sensiblement identique à la séquence d'acides aminés SEQ ID NO:1 ou un sel correspondant et un anticorps de neutralisation inhibant l'activité de la protéine sont utilisables, par exemple, afin de prévenir et de traiter l'asthme, la bronchopneumopathie chronique obstructive, etc. L'ADN antisens peut inhiber l'expression d'une protéine ayant un acide aminé identique ou sensiblement identique à la séquence d'acides aminés SEQ ID NO:1, et on peut l'utiliser, par exemple, afin de prévenir et de traiter l'asthme, la bronchopneumopathie chronique obstructive, etc.
Patent CA-2392810-A1 (CA)
Title: A rapid acting freeze dired oral pharmaceutical composition for treating migraine
Inventor: VENKATESWARA RAO PAVULURI
IPC: A61K9/00
Filed: 2000-08-25
Abstract: The present invention relates to a novel freeze - dried pharmaceutical composition useful for the treatment of migraine and associated symptoms at a reduced total dose of active substance than required for oral administration  in the form of a tablet comtaining a porous matrix net work of a water solub le or water dispersible carrier material, a pharmaceutically active substance(s ); organoleptic additives such as sweetening agents, flavouring agents, colorin g agents; pharmaceutically acceptable preservatives; solublising agents; surfaceactive agents and/or buffereing agents. The pharmaceutical compositio n optionally may contain other additives such as permeation enhancers, chelati ng salts and stabilising agents. The present invention also relates to a proces s for preparation of the above said composition and its use.
Patent CA-2394675-A1 (CA)
Title: Apparatus for sensing the fluid level in an ink and water mixing device
Inventor: VUCKO JOSEPH
IPC: B41F31/03
Filed: 2000-12-08
Abstract: A sensor for detecting the level of circulating fluid in a tank comprises a paddle blade disposed at a particular height and oriented generally radially  from a rotating shaft in the tank. A sensiing device, such as a strain gauge , is attached to the paddle blade (30) to detect when the paddle blade is in a t least one of a normal and a displaced position, thereby indicating that flui d is absent or present at a particular level. Additional sensors may be used i n the same tank to provide fluid level feedback at more than one height.</SDOA B>
Patent CA-2395271-A1 (CA)
Title: Cell culture medium containing growth factors and l-glutamine
Inventor: TIBBE GERHARDUS JOHANNES MARIA
IPC: C12N5/074
Filed: 2000-12-27
Abstract: The invention relates to a culture medium for culturing cells, in particular  human cells in a process for tissue engineering bone. The medium comprises glucose, a mineral, a vitamin, a growth factor and L-glutamine, wherein the L- glutamine is present in a concentration of at least 300 mg/L.
Patent CA-2396930-A1 (CA)
Title: Ink-jet print cartridge having a low profile
Inventor: SANTHANAM RAM
IPC: B41J2/175
Filed: 2000-11-13
Abstract: An ink-jet print cartridge having a low profile. The print cartridge includes a print cartridge body (12), a lid (31) securely affixed to the body, and a latch (50) located on the lid. The print cartridge further includes two elongate supporting lips (29) located along the side walls (25, 26) of the body for supporting the print cartridge during loading. Loading is effected with a plurality of gripping surfaces remotely located from the latch.
Patent CA-2397301-A1 (CA)
Title: Culture d'organismes proies riches en dha pour des especes aquatiques
Inventor: HALLDORSSON OLAFUR
IPC: A23K1/16
Filed: 2001-01-15
Abstract: L'invention concerne une méthode d'élevage d'espèces aquatiques, consistant à nourrir les espèces aquatiques durant au moins une partie de leur vie larvaire et/ou post-larvaire avec des organismes-proies, par exemple des Artémias ou des rotifères, dont le contenu lipidique total contient un contenu en DHA d'au moins 12 % en poids. Cette méthode est adaptée à l'élevage d'espèces de poissons telles que le flétan, le turbot, l'achigan, la brème et la plie.
Patent CA-2398664-A1 (CA)
Title: Apparatus and method for user control of appliances
Inventor: MULLER J JOSEPH
IPC: F41C27/00
Filed: 2002-08-16
Abstract: Apparatus (10) and a method for rendering a weapon (12) incapable of use unless authorized by a specified individual. More than one person may be authorized to use the weapon, however only one person may be authorized to use it at any one time. Each authorized person carries a badge (14) or other device which includes an rf transmitter (TAU) capable of transmitting a coded signal to a receiver (REU) installed in the weapon in response to a coded query from a unit (EU) installed in the weapon. If a properly coded transmission is received by the weapon, it becomes capable of being fired by the person who authorized its use. However, the weapon will not fire unless the person using the weapon is also standing behind the weapon. This prevents the weapon from being turned on the person authorized to use it. The apparatus stores details of the weapon's use (e.g., who, when, and where). This information is released upon receipt of an authorized code.
Patent CA-2400871-A1 (CA)
Inventor: WILDGOOSE PETER
IPC: A61K31/215
Filed: 2001-02-21
Abstract: The present invention relates to new compounds for the inhibition of blood clotting proteins, and more particularly, to malonic acid derivatives of the  formula (I), wherein R(1), R(2), R(3), R(4), R(5), and R(6) have the meaning s indicated in the claims. The compounds of the formula (I) are inhibitors of the blood clotting enzyme factor Xa. The invention also relates to processes  for the preparation of the compounds of formula (I), to methods of inhibitin g factor Xa activity and of inhibiting blood clotting, to the use of the compounds of formula (I) in the treatment and prophylaxis of diseases, which  can be treated or prevented by the inhibition of factor Xa activity such as thromboembolic diseases, and to the use of the compounds of formula (I) in t he preparation of medicaments to be applied in such diseases. The invention further relates to compositions containing a compound of formula (I), in admixture or otherwise in association with an inert carrier, in particular pharmaceutical compositions containing a compound of formula (I) together wi th pharmaceutically acceptable carrier substances and auxiliary substances.</SD OAB>
Patent CA-2402854-A1 (CA)
Title: Communications services provisioning method and apparatus and object programming language for developing provisioning models
Inventor: DIENER GLENDON ROSS
IPC: H04M3/42
Filed: 2001-03-16
Abstract: A provisioning engine for provisioning communications services and a pattern language for configuring the provisioning engine (100). A plurality of objets can be assembled to define provisioning models representing state machines for carrying out common provisioning operations. The state machines include a set of plural current states (110) of the provisioning model, mechanisms for generating signals (132), tasks, and at least one transition operative to define conditions under which the tasks are executed (138) and states (136) are added to or removed from the set of current states (110). Signals (132) can be executed instantaneously or scheduled for later execution to permit provisioning operations to be controlled in a temporal manner. The provisioning models can be executed as specific instances and instances can include calls to other models to be executed as subinstances.
Patent CA-2403128-A1 (CA)
Title: Proton conducting polymer membrane for electrochemical cell
Inventor: HARDS GRAHAM ALAN
IPC: H01M8/10
Filed: 2001-03-16
Abstract: A novel proton conducting polymer membrane which contains a network of voids within the membrane is disclosed. Such a membrane allows for a reservoir of additional water within a fuel cell comprising said membrane, such that water electrolysis is sustained in the cell during incidences of cell reversal.  Methods for the construction of such a membrane are also provided.
Patent CA-2407419-A1 (CA)
Inventor: NEWVILLE TODD A
IPC: H04L29/08
Filed: 2001-04-25
Abstract: A communication system for providing high-speed wireless access to mobile processing systems a stationary transceiver defining an information portal in its immediate vicinity. A local server in communication with this stationary transceiver is configured to respond to a mobile processing-system present within the information portal.
Patent CA-2409162-A1 (CA)
Title: Enhanced duration fragrance delivery systems having a non-distorted initial fragrance impression
Inventor: HOLLAND LYNETTE ANNE MAKINS
IPC: A61K8/37
Filed: 2001-06-01
Abstract: The present invention relates to sustained release fragrance accords wherein the initial fragrance release or bouquet is not distorted by the presence of an unbalanced accord. The systems of the present invention comprise: a) a pro-fragrance component; and b) a free fragrance component. The present invention further relates to compositions comprising the fragrance raw materials systems and processes for preparing said systems.
Patent CA-2409517-A1 (CA)
Inventor: WOBBEN ALOYS
IPC: F03D80/00
Filed: 2001-03-31
Abstract: L'invention concerne un procédé pour disposer des éoliennes dans un parc d'éoliennes. Ce procédé consiste à évaluer le potentiel d'un site prévu pour l'implantation d'un parc d'éoliennes, au moyen d'un calculateur ou d'un ordinateur et d'un programme de calcul faisant intervenir des données topographiques de la surface terrestre.
Patent CA-2409923-A1 (CA)
Inventor: CORDIER MURIEL LEILA GISELE
IPC: D06M13/148
Filed: 2001-05-18
Abstract: L'invention concerne une composition assouplissante comprenant entre environ 1 et 90 % en poids d'une substance active assouplissante; éventuellement entre environ 1 et 25 % en poids d'un solvant principal ayant un ClogP inférieur à environ 3; entre environ 0,05 et 15 % en poids d'un agent de neutralisation des mauvaises odeurs; l'équilibre étant apporté par des ingrédients adjoints. L'agent de neutralisation des mauvaises odeurs est sélectionné dans le groupe constitué par un agent antimicrobien d'ammonium quaternaire, la cyclodextrine ou des mélanges de ces ingrédients. L'invention concerne également un procédé d'atténuation des mauvaises odeurs consistant à utiliser cette composition avec un article textile puis à sécher ledit article textile, ainsi que l'utilisation de cette composition avec des articles textiles pour diminuer la sensation de mauvaise odeur. Elle concerne en outre un article destiné à atténuer ou éliminer l'expression d'une sensation de mauvaise odeur.
Patent CA-2412465-A1 (CA)
Inventor: ALLOUCHE REGINALD
IPC: A23L33/20
Filed: 2001-06-14
Abstract: The invention concerns a high-protein and low calorie dietetic product, in the form of a sweet or savoury cake, cooked and deep-frozen. Said deep-frozen high-protein and low-calorie cake has a protein content ranging between 15 and 25 %; a carbohydrate content between 5 and 10 % and a lipid content between 1 and 5 %. Its water content ranges between 40 and 72 % and its calorie value ranges between 120 and 200 Kcal per 100 g.
Patent CA-2414941-A1 (CA)
Title: Compositions including ammonia oxidizing bacteria to increase production of nitric oxide and nitric oxide precursors and methods of using same
Inventor: WHITLOCK DAVID R
IPC: A61K35/74
Filed: 2001-08-10
Abstract: A method of enhancing health through the generation in close proximity of a surface of a subject, nitric oxide and nitric oxide precursors using bacteria adapted to oxidize ammonia and urea derived from perspiration is described. Local and systemic effects are described including reduction in vascular disease, enhancement of sexual function, improved skin health, and reduced transmission of sexually transmitted diseases.
Patent CA-2415218-A1 (CA)
Inventor: DEMONE PAUL
IPC: G11C8/18
Filed: 2001-07-06
Abstract: A circuit for synchronizing row and column access operations in a semiconductor memory having an array of bit lines pairs, word lines, memory cells, sense amplifiers, and a sense amplifier power supply circuit for powering the sense amplifiers, the circuit comprising, a first delay circuit  for delaying a word line timing pulse by a first predetermined period, a fir st logic circuit for logically combining the word line timing pulse and the delayed word line timing pulse to produce a sense amplifier enable signal, f or enabling a sense amplifier power supply circuit, a second delay circuit for delaying the word line timing pulse by a second predetermined period, and a second logic circuit for logically combining the word line timing pulse and the second delayed word line timing pulse to produce a column select enable signal, for enabling selected ones of a plurality of column access devices wherein the second predetermined time period is selected so that ones of a plurality of column access devices are activated after the sense amplifier power supply circuit is enabled.
Patent CA-2418841-A1 (CA)
Inventor: STUBBEN BRUNO
IPC: D06N3/00
Filed: 2001-07-30
Abstract: The invention relates to an embossed, PUR system-coated textile fabric, to a  method for producing the same and to the use of a fabric of this type as a decorative starting material. The inventive fabrics, which have a residual shrinkage, are coated with PUR and then post-treated using heat.
Patent CA-2419001-A1 (CA)
Title: Porte-bandelettes a utiliser dans un compteur de bandelettes test
Inventor: OLSON LORIN
IPC: G01N21/01
Filed: 2001-07-26
Abstract: L'invention concerne des porte-bandelettes test ~ utiliser avec des compteurs de bandelettes test. Ces porte-bandelettes comprennent au moins une ouverture et un rebord associ~ ~ ladite ouverture. L'~l~ment rebord de ces porte-bandelettes est capable de former un scellement de liquide avec la surface sup~rieure d'une bandelette test au moment de l'introduction de celle-ci dans l'ouverture. Dans plusieurs modes de r~alisation de l'invention, le porte-bandelettes est con×u de mani­re ~ entourer, au moins partiellement, une r~gion d'application d'~chantillons d'une bandelette test au moment de l'introduction de celle-ci dans l'ouverture. L'invention concerne ~galement des compteurs sur lesquels les porte-bandelettes de test selon l'invention sont pr~sents, ainsi que des proc~d~s d'utilisation associ~s.
Patent CA-2423444-A1 (CA)
Inventor: ZELSKI MICHAEL
IPC: A23L35/00
Filed: 2003-03-25
Abstract: A kit for making a savory meal is described. The kit has IQF vegetables and a dry, free-flowing powder that. can be added to a boiling liquid to produce a savory meal in under 25 minutes.
Patent CA-2425277-A1 (CA)
Title: Surgical instrument
Inventor: BRACKE ANDREAS
IPC: A61B18/20
Filed: 2001-10-11
Abstract: A surgical instrument is disclosed, preferably for the minimally invasive intervention in human or animal tissues, comprising a, for example, needle- shaped base body (3) with at least one passage formed from a hollow fibre (2 ). The at least one hollow fibre (2) is surrounded by a matrix (5) of a fibre composite material. The use of a hollow fibre (2) permits a simple productio n, in particular, of instruments with a number of passages. The use of more tha n one hollow fibre (2) within the base body (3) increases the application possibilities, for example, simultaneous monitoring and treatment of the tissue.
Patent CA-2425685-A1 (CA)
Inventor: SUNDERMANN CORINNA
IPC: A61P29/00
Filed: 2001-10-10
Abstract: L'invention concerne des 3,4-dihydro-pyrimido[1,2-a]pyrimidines substituées et des 3,4-dihydro-pyrazino[1,2-a]pyrimidines substituées de formule générale (I), leur procédé de production, des bibliothèques de substances les contenant, des médicaments comportant ces composés, l'utilisation de ces composés pour la préparation de médicaments destinés au traitement de la douleur, de l'incontinence urinaire, des démangeaisons, du tinnitus auriculaire et/ou de la diarrhée, ainsi que des préparations pharmaceutiques contenant ces composés.
Patent CA-2427629-A1 (CA)
Inventor: FLOYD ROBERT A
IPC: A61P25/16
Filed: 2001-11-01
Abstract: L'invention concerne un procédé visant à réguler l'expression génique associée au métabolisme du fer afin de traiter des maladies telles que la drépanocytose, les cancers, les maladies neurodégénératives, l'ataxie de Friedreich et d'autres affections neuromusculaires, et l'athérosclérose. Ce procédé s'appuie sur des découvertes récentes selon lesquelles la H ferritine, une protéine fixatrice du fer présente dans les noyaux cellulaires, est capable de réprimer le gène humain de .beta.-globine, ce gène étant mutant dans la drépanocytose. L'expression accrue de H ferritine ou d'un peptide associé de la famille des ferritines, introduit (e) dans des cellules traitées soit comme peptide même (ou partie de peptide), comme clone d'expression du gène appartenant à la sous-famille des H ferritines, soit par l'intermédiaire d'un régulateur de gène qui accroît l'expression du gène appartenant à la sous-famille des H ferritines, permet de prévenir ou de traiter des affections dont l'étiologie comprend une assimilabilité accrue du fer, y compris les affections mentionnées.
Patent CA-2433015-A1 (CA)
Inventor: HSU CHE-HSIUNG
IPC: C08L79/00
Filed: 2002-01-30
Abstract: The present invention is generally directed to a polyaniline/high molecular weight polymeric sulfonic acid complex made by oxidative polymerization, and aqueous polyaniline dispersions, where the viscosity of the dispersion has been increased by the presence of the high molecular weight polymeric sulfon ic acids during the polymerization process.
Patent CA-2434760-A1 (CA)
Inventor: GOLD JOSEPH D
IPC: A61K35/12
Filed: 2001-11-26
Abstract: L'invention concerne un système servant à produire des cellules différenciées à partir d'une population de cellules souches et conçu pour être mis en application lorsqu'on désire obtenir une population cellulaire relativement homogène. Ces cellules contiennent un gène effecteur contrôlé par un élément de transcription (tel que le promoteur TERT) provoquant l'expression du gène dans des cellules relativement indifférenciées de la population. L'expression de ce gène effecteur provoque l'appauvrissement de cellules indifférenciées ou l'expression d'un marqueur pouvant être utilisé afin de supprimer ces cellules ultérieurement. Des séquences effectrices appropriées codent une toxine, une protéine induisant l'apoptose, un antigène de surface cellulaire ou un enzyme (tel que thymidine kinase) convertissant un promédicament en une substance mortelle pour la cellule. Ces populations de cellules différenciées préparées selon l'invention sont utilisées avantageusement pour la régénération tissulaire, ainsi que dans des mises en application non thérapeutiques, telles que le criblage de médicaments.
Patent CA-2435179-A1 (CA)
Inventor: DILGER JOHN P
IPC: G05D16/20
Filed: 2001-12-14
Abstract: A magnet assembly is disclosed for use with a magnetic flux sensor to provide a position sensor adapted to detect a position of a moveable member. The magnet assembly comprises a magnet housing defining an inner surface. A magnet is provided that is sized for insertion into the magnet housing and adapted for movement with the moveable member, the magnet having a north pole and a south pole, wherein the magnet generates a magnetic flux. A centering ring is positioned between the magnet and the magnet housing, the centering ring including a biased wall acting to center the magnet in the magnet housing.
Patent CA-2435847-A1 (CA)
Title: Aniline derivatives useful as phosphodiesterase 4 inhibitors
Inventor: BRUBAKER WILLIAM FREDERICK JR
IPC: A61K31/136
Filed: 2002-01-22
Abstract: PDE4 inhibition is achieved by novel compounds, e.g., N-substituted aniline and diphenylamine analogs. The compounds of the present invention are of Formula (I): wherein R1, R2, R3 and R4 are as defined herein.
Patent CA-2440039-A1 (CA)
Title: Portable mini exercise-bike
Inventor: BALBO ALBERTO
IPC: A63B21/22
Filed: 2002-03-09
Abstract: The portable mini exercise-bike which occupies a minimum space, is made up o f a pedal section (100) which by means of supporting elements is fixed to a resting surface. The fixing element used to fix the mini exercise-bike to th e resting surface, can be realized with a suction cup (10) or a base plate (63 , 83). On the pedal (45) of the pedal section, a removable pedal cover (46) fi ts perfectly, on which are placed slippers (47), having slots (50) to allow straps to pass. The pedal covers (46) have a lateral element with a nut scre w (52) which permits the screwing of a rod (53). On the axle of pedal (45) it is possible to insert a specially formed handle instead of the pedals, using straps to fix the hand in position. A flywheel (63) can be assembled with th e mini exercise-bike.
Patent CA-2442120-A1 (CA)
Title: Survival dwdm system
Inventor: CAPRINO GIOVANNI
IPC: H04J14/02
Filed: 2002-03-26
Abstract: A traffic survival method in optical fiber telecommunication systems and in particular DWDM and having amplification sites (10) with ADD/DROP of channels and arranged between fiber spans is described and claimed. In accordance with the method the ASE noise produced in amplifiers (13) in the site is amplified in power to compensate at output the power of channels (n) lost by breakage of the site input span. An amplification device with ADD/DROP and a telecommunication system with it is also described and claimed.
Patent CA-2442964-A1 (CA)
Inventor: NEWMARK THOMAS
IPC: A61P19/02
Filed: 2002-03-28
Abstract: L'invention concerne une composition à administration orale ou topique capable de diminuer l'inflammation chez les animaux, de préférence les humains, souffrant d'inflammation. Cette composition contient une quantité efficace du point de vue thérapeutique d'un extrait post-supercritique de gingembre à base d'alcool et de dioxyde de carbone; des quantités efficaces du point de vue thérapeutique d'extraits supercritiques de romarin, de curcuma, d'origan et de gingembre à base de dioxyde de carbone (de préférence certifié gingembre organique); et des quantités efficaces du point de vue thérapeutique d'extraits aqueux à base d'alcool, de basilic, de curcuma, de scutellaire du Baïkal, de romarin, de thé vert, de renouée japonaise, de coptide chinoise et de vinette. De préférence, cette composition est administrée quotidiennement par voie orale pendant au moins environ 4 semaines.
Patent CA-2444095-A1 (CA)
Inventor: ZHOU PING
IPC: A61P25/28
Filed: 2002-04-19
Abstract: The present invention provides a compound of formula (I) and the use thereof for the therapeutic treatment of disorders relating to or affected by the 5-HT6 receptor.